Supplemental material
Human Vaccines & Immunotherapeutics
Volume 17, 2021 - Issue 7
Research Paper
Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore: 2-year follow-up of a randomized phase II, placebo-controlled trial
, , , 
, , , , , , , & show all
Lynette Pei-Chi Sheke Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singaporehttps://orcid.org/0000-0001-9064-8983View further author information
https://orcid.org/0000-0001-9064-8983View further author information, , , , , Frederique Jantet-Blaudezh Research and External Innovation Department, Sanofi Pasteur, Marcy l’Etoile, Francehttps://orcid.org/0000-0002-7139-9042View further author information
https://orcid.org/0000-0002-7139-9042View further author information, , & Anke Pagnonh Research and External Innovation Department, Sanofi Pasteur, Marcy l’Etoile, Francehttps://orcid.org/0000-0001-9295-3439View further author information
https://orcid.org/0000-0001-9295-3439View further author information show all